相关实验视频
Updated: Jul 20, 2026

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Wnt信号,Ca2+和循环GMP:可视化Frizzled的功能
Hsien-Yu Wang1, Craig C Malbon
1Department of Physiology and Biophysics, Health Sciences Center, State University of New York at Stony Brook, Stony Brook, NY 11794-8661, USA.
概括
Wnt蛋白通过各种途径调节细胞发育,包括β-catenin信号传递和影响细胞内和cGMP水平. 这些信号级联涉及G蛋白和RGS蛋白,将Wnt功能与视觉通路元素联系起来.
科学领域:
- 细胞生物学 细胞生物学
- 发育生物学 发展生物学
- 分子信号传输的方法
背景情况:
- Wnt蛋白质是关键的信号分子,调节细胞的基本过程,如细胞命运规范,粘附,迁移,极性和增殖.
- 它们在胚胎发育中的多样性作用在各种模型生物中得到了广泛的研究,包括果,线虫,斑马鱼,青和小鼠.
- Wnt信号通路是复杂的,一些通路调节β-catenin降解以控制基因转录,而另一些则通过不同的机制运作.
研究的目的:
- 为了阐明Wnt信号传递超出正规β-catenin通路的多面机制.
- 调查G蛋白和RGS蛋白在非正规Wnt信号传输中的参与.
- 探索Wnt介导的细胞内和cGMP调节与已知的信号通路之间的联系.
主要方法:
- 这项研究可能涉及分子生物学技术,以探测Wnt信号通路.
- 研究了β-catenin在Wnt介导的基因调节中的作用.
- 研究了Wnt信号对细胞内Ca2+和循环氨酸单酸盐 (cGMP) 度的影响.
- 评估了异构三元核酸结合蛋白 (G蛋白) 和RGS蛋白在这些过程中的参与.
主要成果:
- 确定了不同的Wnt信号通路,包括调节β-catenin和调节细胞内Ca2+和cGMP水平的通路.
- 证明了Wnt对Ca2+和cGMP的调节需要视觉信号通路的特定组件,即G蛋白转化素和cGMP特定的化酶.
- 突出了G蛋白和RGS蛋白在调解Wnt信号传导中的参与.
结论:
- Wnt信号包括多种途径,包括影响离子度的正规β-catenin依赖和非正规途径.
- 视觉信号通路的特定组件,如转化素和cGMP特异性化酶,对于某些Wnt介导的细胞反应至关重要.
- 这项研究扩大了对Wnt信号复杂性及其与其他细胞过程的整合的理解.
相关概念视频
Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...

